https://kengarber.com/2025/07/07/probing-the-proteome-nature-biotechnology/2025-07-07T20:57:40+00:00monthlyhttps://kengarber.com/2025/07/05/menin-inhibitors-seek-to-debut-as-newest-targeted-therapy-for-leukaemia/2025-07-05T15:08:44+00:00monthlyhttps://kengarber.com/2023/09/05/hunt-for-improved-monoclonals-against-coronavirus-gathers-pace/2023-09-05T20:18:46+00:00monthlyhttps://kengarber.com/2020/05/08/immune-agonist-antibody-faces-critical-test-nature-reviews-drug-discovery/2020-05-08T14:39:48+00:00monthlyhttps://kengarber.com/2020/04/04/the-new-liver-epidemic/2020-04-04T17:03:18+00:00monthlyhttps://kengarber.com/about/2020-04-04T16:53:06+00:00weekly0.6https://kengarber.com/2018/12/31/oncologists-await-historic-first-a-pan-tumor-predictive-marker-for-immunotherapy/2018-12-31T20:06:22+00:00monthlyhttps://kengarber.com/2018/03/20/bristol-myers-squibb-locks-into-novel-autoimmune-strategy/2018-03-20T16:02:18+00:00monthlyhttps://kengarber.com/2017/01/26/natural-killer-cells-blaze-into-immuno-oncology-nature-biotechnology/2017-01-26T22:00:13+00:00monthlyhttps://kengarber.com/2016/06/15/targeting-copper-to-treat-breast-cancer-science-magazine/2016-09-15T18:01:07+00:00monthlyhttps://kengarber.com/2016/09/15/protein-drops-may-seed-brain-disease-science-magazine/2016-09-15T18:00:17+00:00monthlyhttps://kengarber.com/2016/04/21/a-beta-lactamase-inhibitor-revival-provides-new-hope-for-old-antibiotics/2016-04-21T15:12:14+00:00monthlyhttps://kengarber.com/2015/11/17/drugging-the-gut-microbiome/2015-11-17T22:00:23+00:00monthlyhttps://kengarber.com/2015/06/29/bispecific-antibodies-rise-again-nature-reviews-drug-discovery/2015-06-29T20:06:03+00:00monthlyhttps://kengarber.com/2015/03/03/the-cancer-drug-that-almost-wasnt-science/2015-03-03T22:48:36+00:00monthlyhttps://kengarber.com/2014/12/16/met-inhibitors-start-on-road-to-recovery/2015-01-19T14:42:54+00:00monthlyhttps://kengarber.com/2015/01/05/between-disease-and-a-dish-nature-biotechnology/2015-01-05T17:12:27+00:00monthlyhttps://kengarber.com/2014/06/09/potential-alzheimers-drug-spurs-protein-recycling/2014-06-10T01:26:15+00:00monthlyhttps://kengarber.com/2014/04/09/parp-inhibitors-bounce-back/2014-04-09T15:36:33+00:00monthlyhttps://kengarber.com/2014/01/02/at-the-frontiers-of-lung-fibrosis-therapy/2014-01-02T15:07:57+00:00monthlyhttps://kengarber.com/2013/07/05/inducing-translation-nature-biotechnology/2014-01-02T15:00:20+00:00monthlyhttps://kengarber.com/2013/07/05/a-radical-treatment-nature/2014-01-02T14:58:43+00:00monthlyhttps://kengarber.com/contact2-2/2013-03-11T23:06:33+00:00weekly0.6https://kengarber.com/2013/01/14/neuroscience-all-eyes-on-rna/2013-01-26T13:34:21+00:00monthlyhttps://kengarber.com/2012/08/27/presymptomatic-alzheimers-trials-prepare-to-launch/2012-10-23T13:31:49+00:00monthlyhttps://kengarber.com/2012/06/12/at-loose-ends-telomere-theories-of-aging-and-cancer-begin-to-converge/2012-08-27T13:52:50+00:00monthlyhttps://kengarber.com/2011/11/05/ready-or-not-personal-tumor-profiling-tests-take-off/2012-06-12T15:12:24+00:00monthlyhttps://kengarber.com/2011/11/04/hello-world/2012-06-12T15:10:17+00:00monthlyhttps://kengarber.com/2011/11/07/inducing-indigestion-companies-embrace-autophagy-inhibitors/2012-06-12T15:09:42+00:00monthlyhttps://kengarber.com/2012/01/23/hepatitis-c-move-over-interferon/2012-06-12T15:09:13+00:00monthlyhttps://kengarber.com/2012/02/11/genetic-discoveries-propagate-new-epigenetic-drugs/2012-06-12T15:08:43+00:00monthlyhttps://kengarber.com/2012/03/06/autophagy-explaining-exercise/2012-06-12T15:07:13+00:00monthlyhttps://kengarber.com/articles-2/2011-11-05T13:36:52+00:00weekly0.6https://kengarber.comdaily1.02025-07-07T20:57:40+00:00